Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Chromatin dynamics during cellular reprogramming.

Apostolou E, Hochedlinger K.

Nature. 2013 Oct 24;502(7472):462-71. doi: 10.1038/nature12749. Review.

2.

Epigenetics of cellular reprogramming.

Krishnakumar R, Blelloch RH.

Curr Opin Genet Dev. 2013 Oct;23(5):548-55. doi: 10.1016/j.gde.2013.06.005. Epub 2013 Aug 12. Review.

3.

Reprogramming chromatin.

Ehrensberger AH, Svejstrup JQ.

Crit Rev Biochem Mol Biol. 2012 Sep;47(5):464-82. doi: 10.3109/10409238.2012.697125. Epub 2012 Jul 3. Review.

PMID:
22757592
4.

Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?

Jullien J, Pasque V, Halley-Stott RP, Miyamoto K, Gurdon JB.

Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):453-9. doi: 10.1038/nrm3140. Review.

5.

Epigenetics of reprogramming to induced pluripotency.

Papp B, Plath K.

Cell. 2013 Mar 14;152(6):1324-43. doi: 10.1016/j.cell.2013.02.043. Review.

6.

Generation of human induced pluripotent stem cells using epigenetic regulators reveals a germ cell-like identity in partially reprogrammed colonies.

Goyal A, Chavez SL, Reijo Pera RA.

PLoS One. 2013 Dec 12;8(12):e82838. doi: 10.1371/journal.pone.0082838. eCollection 2013.

7.

Reprogramming of cell fate: epigenetic memory and the erasure of memories past.

Nashun B, Hill PW, Hajkova P.

EMBO J. 2015 May 12;34(10):1296-308. doi: 10.15252/embj.201490649. Epub 2015 Mar 27. Review.

8.

Epigenetic memory in induced pluripotent stem cells.

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ.

Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.

9.

Reprogramming factor expression initiates widespread targeted chromatin remodeling.

Koche RP, Smith ZD, Adli M, Gu H, Ku M, Gnirke A, Bernstein BE, Meissner A.

Cell Stem Cell. 2011 Jan 7;8(1):96-105. doi: 10.1016/j.stem.2010.12.001.

10.

Mechanistic insights into reprogramming to induced pluripotency.

Ho R, Chronis C, Plath K.

J Cell Physiol. 2011 Apr;226(4):868-78. doi: 10.1002/jcp.22450. Review.

11.

Genome-wide characterization of the routes to pluripotency.

Hussein SM, Puri MC, Tonge PD, Benevento M, Corso AJ, Clancy JL, Mosbergen R, Li M, Lee DS, Cloonan N, Wood DL, Munoz J, Middleton R, Korn O, Patel HR, White CA, Shin JY, Gauthier ME, Lê Cao KA, Kim JI, Mar JC, Shakiba N, Ritchie W, Rasko JE, Grimmond SM, Zandstra PW, Wells CA, Preiss T, Seo JS, Heck AJ, Rogers IM, Nagy A.

Nature. 2014 Dec 11;516(7530):198-206. doi: 10.1038/nature14046. Erratum in: Nature. 2015 Jul 30;523(7562):626.

PMID:
25503233
12.

Derivation of novel human ground state naive pluripotent stem cells.

Gafni O, Weinberger L, Mansour AA, Manor YS, Chomsky E, Ben-Yosef D, Kalma Y, Viukov S, Maza I, Zviran A, Rais Y, Shipony Z, Mukamel Z, Krupalnik V, Zerbib M, Geula S, Caspi I, Schneir D, Shwartz T, Gilad S, Amann-Zalcenstein D, Benjamin S, Amit I, Tanay A, Massarwa R, Novershtern N, Hanna JH.

Nature. 2013 Dec 12;504(7479):282-6. doi: 10.1038/nature12745. Epub 2013 Oct 30. Erratum in: Nature. 2015 Apr 30;520(7549):710.

PMID:
24172903
13.

Epigenetic reprogramming in cancer.

Suvà ML, Riggi N, Bernstein BE.

Science. 2013 Mar 29;339(6127):1567-70. doi: 10.1126/science.1230184. Review.

14.

Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.

Tiemann U, Wu G, Marthaler AG, Schöler HR, Tapia N.

Stem Cell Reports. 2016 Jan 12;6(1):35-43. doi: 10.1016/j.stemcr.2015.11.007. Epub 2015 Dec 17.

15.

The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.

Mansour AA, Gafni O, Weinberger L, Zviran A, Ayyash M, Rais Y, Krupalnik V, Zerbib M, Amann-Zalcenstein D, Maza I, Geula S, Viukov S, Holtzman L, Pribluda A, Canaani E, Horn-Saban S, Amit I, Novershtern N, Hanna JH.

Nature. 2012 Aug 16;488(7411):409-13. doi: 10.1038/nature11272.

PMID:
22801502
16.

Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?

Yilmazer A, de Lázaro I, Taheri H.

Cancer Lett. 2015 Dec 1;369(1):1-8. doi: 10.1016/j.canlet.2015.06.027. Epub 2015 Aug 11. Review.

PMID:
26276716
17.

Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.

Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, Plath K.

Nat Cell Biol. 2013 Jul;15(7):872-82. doi: 10.1038/ncb2768. Epub 2013 Jun 9.

18.

Progress in understanding reprogramming to the induced pluripotent state.

Plath K, Lowry WE.

Nat Rev Genet. 2011 Apr;12(4):253-65. doi: 10.1038/nrg2955. Review.

19.

Chromatin-modifying enzymes as modulators of reprogramming.

Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ.

Nature. 2012 Mar 4;483(7391):598-602. doi: 10.1038/nature10953.

20.

Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?

Bilic J, Izpisua Belmonte JC.

Stem Cells. 2012 Jan;30(1):33-41. doi: 10.1002/stem.700. Review.

Supplemental Content

Support Center